120 related articles for article (PubMed ID: 35365394)
1. An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort.
Smith HB; Schneider E; Tanner NT
Am J Prev Med; 2022 Aug; 63(2):e59-e64. PubMed ID: 35365394
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.
Kim RY; Rendle KA; Mitra N; Saia CA; Neslund-Dudas C; Greenlee RT; Burnett-Hartman AN; Honda SA; Simoff MJ; Schapira MM; Croswell JM; Meza R; Ritzwoller DP; Vachani A
Ann Am Thorac Soc; 2022 Sep; 19(9):1561-1569. PubMed ID: 35167781
[No Abstract] [Full Text] [Related]
3. Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings.
Sakoda LC; Rivera MP; Zhang J; Perera P; Laurent CA; Durham D; Huamani Velasquez R; Lane L; Schwartz A; Quesenberry CP; Minowada G; Henderson LM
JAMA Netw Open; 2021 Apr; 4(4):e218559. PubMed ID: 33929519
[TBL] [Abstract][Full Text] [Related]
4. Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a Centralized Approach.
Smith HB; Ward R; Frazier C; Angotti J; Tanner NT
Chest; 2022 Mar; 161(3):818-825. PubMed ID: 34536385
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
[TBL] [Abstract][Full Text] [Related]
6. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
8. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
9. Age, Race, and Income Are Associated With Lower Screening Rates at a Safety Net Hospital.
Steiling K; Loui T; Asokan S; Nims S; Moreira P; Rebello A; Litle VR; Suzuki K
Ann Thorac Surg; 2020 May; 109(5):1544-1550. PubMed ID: 31981498
[TBL] [Abstract][Full Text] [Related]
10. Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility.
Maki KG; Talluri R; Toumazis I; Shete S; Volk RJ
Cancer Med; 2023 Feb; 12(4):4647-4654. PubMed ID: 35871312
[TBL] [Abstract][Full Text] [Related]
11. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis.
Kunitomo Y; Bade B; Gunderson CG; Akgün KM; Brackett A; Cain H; Tanoue L; Bastian LA
Chest; 2022 Jan; 161(1):266-275. PubMed ID: 34390706
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
14. The aggregate value of cancer screenings in the United States: full potential value and value considering adherence.
Philipson TJ; Durie T; Cong Z; Fendrick AM
BMC Health Serv Res; 2023 Aug; 23(1):829. PubMed ID: 37550686
[TBL] [Abstract][Full Text] [Related]
15. How the Expansion of the U.S. Preventive Services Task Force Lung Cancer Screening Eligibility May Improve Health Equity Among Diverse Sexual and Gender Minority Populations.
Tan ASL; Potter J
LGBT Health; 2021 Nov; 8(8):503-506. PubMed ID: 34619037
[TBL] [Abstract][Full Text] [Related]
16. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
[TBL] [Abstract][Full Text] [Related]
17. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
